Current status of prophylactic surgical treatment for familial adenomatous polyposis in Japan

Masato Yamadera1, Hideki Ueno2, Hirotoshi Kobayashi3

  • 1Department of Surgery, National Defense Medical College, Saitama, Japan.

Surgery Today
|October 23, 2016
PubMed

Insights

Prophylactic colectomy for familial adenomatous polyposis (FAP) in Japan shows good short-term outcomes. Current practices involve limited indications for attenuated FAP, delayed colectomy, and increased laparoscopic surgery use.

Area of Science:

  • Gastroenterology
  • Surgical Oncology
  • Clinical Genetics

Background:

  • Familial adenomatous polyposis (FAP) is a hereditary condition predisposing individuals to colorectal cancer.
  • Prophylactic colectomy is a standard management strategy for FAP patients to prevent cancer development.
  • Understanding current surgical practices is crucial for optimizing patient outcomes.

Purpose of the Study:

  • To clarify the contemporary clinical practice of prophylactic colectomy for FAP in Japan.
  • To evaluate trends in surgical indications, timing, and techniques over time.

Main Methods:

  • A retrospective multi-center cohort study involving 147 FAP patients who underwent prophylactic colectomy between 2000 and 2012.
  • Data were collected from 23 specialized colorectal disease institutions in Japan.
  • Patients were categorized into two groups based on surgery date: Group 1 (2000-2006) and Group 2 (2007-2012).

Main Results:

  • The mean age at prophylactic surgery increased from 27 to 31 years between Group 1 and Group 2.
  • The proportion of attenuated FAP cases decreased significantly in Group 2 (1.0%) compared to Group 1 (13%).
  • Malignant polyps were more frequent in Group 2 resections (23%) versus Group 1 (10%), with a P-value of 0.034. Laparoscopic surgery increased from 40% in Group 1 to 61% in Group 2.

Conclusions:

  • Prophylactic colectomy for FAP in Japan yields favorable short-term surgical outcomes.
  • Current practices indicate a trend towards more selective surgical indications for attenuated FAP.
  • There is a discernible shift towards delayed colectomy and increased adoption of laparoscopic surgical approaches.
Abstract

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
798
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
586
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
829